1.
|
7 p, 568.4 KB |
The more you take it, the better it works : Six-month results of a nalmefene phase-IV trial
/
Barrio, Pablo (Hospital Clínic i Provincial de Barcelona) ;
Roncero, Carlos (Universidad de Salamanca) ;
Ortega, Lluisa (Hospital Clínic i Provincial de Barcelona) ;
Guardia, Josep (Institut d'Investigació Biomèdica Sant Pau) ;
Yuguero, Lara (Germanes Hospitalàries) ;
Gual, Antoni (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
Alcohol use disorders remain a major health problem. Reduced drinking has been increasingly recognized as a valuable alternative to abstinence. Nalmefene has shown in previous, experimental studies to be a useful tool to aid reduced drinking. [...]
2019 - 10.3390/jcm8040471
Journal of clinical medicine, Vol. 8 Núm. 4 (april 2019) , p. 471
|
|
2.
|
12 p, 1.7 MB |
A Feasibility Study of Patients with Major Depression and Substance Use Disorders : Vortioxetine as Maintenance Treatment
/
Basurte-Villamor, Ignacio (Clínica López Ibor) ;
Vega, Pablo (Madrid Salud) ;
Roncero, Carlos (Universidad de Salamanca) ;
Martínez-Raga, José (Hospital Universitari Doctor Peset (València)) ;
Grau-López, Lara (Hospital Universitari Vall d'Hebron) ;
Aguilar, Lourdes (Universidad de Salamanca) ;
Torrens, Marta (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Szerman, Nestor (Hospital General Universitario Gregorio Marañón) ;
Universitat Autònoma de Barcelona
Limited studies have evaluated the effectiveness of vortioxetine in real-world settings, and none of them has involved patients with dual depression (major depressive disorder [MDD] and substance use disorder [SUD]). [...]
2022 - 10.2147/NDT.S358782
Neuropsychiatric Disease and Treatment, Vol. 18 (may 2022) , p. 965-976
|
|
3.
|
11 p, 1.2 MB |
The challenge of community mental health interventions with patients, relatives, and health professionals during the COVID-19 pandemic : a real-world 9-month follow-up study
/
Roncero, Carlos (Instituto de Investigación Biomédica de Salamanca) ;
González-Sánchez, Armando (Universidad de Salamanca) ;
Pérez-Laureano, Ángela (Universidad de Salamanca) ;
Ortiz-Fune, Carmen (Universidad de Salamanca) ;
Díaz-Trejo, Sara (Universidad de Salamanca) ;
Bersabé-Pérez, Miriam (Universidad de Salamanca) ;
Braquehais, María Dolores (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pérez-Rodríguez, Javier (Universidad de Salamanca) ;
Maderuelo-Fernandez, Jose-Angel (Universidad de Salamanca) ;
Benito-Sánchez, José Antonio (Instituto de Investigación Biomédica de Salamanca) ;
Universitat Autònoma de Barcelona
Since the beginning of the COVID-19 pandemic, the need to implement protocols that respond to the mental health demands of the population has been demonstrated. The PASMICOR programme started in March 2020, involving a total of 210 requests for treatment. [...]
2022 - 10.1038/s41598-022-25297-w
Scientific reports, Vol. 12 (december 2022)
|
|
4.
|
9 p, 230.8 KB |
Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life
/
Palma-Álvarez, Raúl Felipe (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Ros-Cucurull, Elena (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Daigre, Constanza (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Perea-Ortueta, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Serrano-Pérez, Pedro (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Martínez-Luna, Nieves (Hospital Universitari Vall d'Hebron) ;
Salas-Martínez, Anna (Hospital Universitari Vall d'Hebron) ;
Robles-Martínez, María (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Ramos-Quiroga, Josep Antoni (Centro de Investigación Biomédica en Red de Salud Mental) ;
Roncero, Carlos (Universidad de Salamanca) ;
Grau-López, Lara (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
Background: Alexithymia frequently correlates with several psychiatric disorders, including substance use disorder (SUD). However, most studies reporting the associations between alexithymia and psychiatric disorders have been performed in populations without SUD. [...]
2021 - 10.3389/fpsyt.2021.659063
Frontiers in psychiatry, Vol. 12 (april 2021)
|
|
5.
|
7 p, 725.5 KB |
Neuroticism Associated with Cocaine-Induced Psychosis in Cocaine-Dependent Patients : A Cross-Sectional Observational Study
/
Roncero, Carlos (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Daigre, Constanza (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Barral, Carmen (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Ros-Cucurull, Elena (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Grau-López, Lara (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Rodríguez-Cintas, Laia (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Tarifa, Nuria (Hospital Universitari Vall d'Hebron) ;
Casas Brugué, Miquel (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Valero, Sergi (Hospital Universitari Vall d'Hebron)
Cocaine consumption can induce transient psychotic symptoms, which has been correlated with more severe addiction and aggressive behavior. However, little is known about the nature of the relationship between personality traits and psychotic symptoms in cocaine-dependent patients. [...]
2014 - 10.1371/journal.pone.0106111
PloS one, Vol. 9 (september 2014)
|
|
6.
|
8 p, 1.0 MB |
Association of the PLCB1 gene with drug dependence
/
Cabana-Domínguez, Judit (Institut de Recerca Sant Joan de Déu) ;
Roncero, Carlos (Hospital Universitari Vall d'Hebron) ;
Pineda-Cirera, Laura (Institut de Recerca Sant Joan de Déu) ;
Palma-Álvarez, Raúl Felipe (Hospital Universitari Vall d'Hebron) ;
Ros-Cucurull, Elena (Hospital Universitari Vall d'Hebron) ;
Grau-López, Lara (Hospital Universitari Vall d'Hebron) ;
Esojo, Abderaman (Hospital Universitari Vall d'Hebron) ;
Casas Brugué, Miquel (Hospital Universitari Vall d'Hebron) ;
Arenas, Concepció (Universitat de Barcelona. Departament de Genètica, Microbiologia i Estadística) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Ribasés Haro, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Fernàndez-Castillo, Noèlia (Institut de Recerca Sant Joan de Déu) ;
Cormand, Bru (Institut de Recerca Sant Joan de Déu) ;
Universitat Autònoma de Barcelona
Genetic factors involved in the susceptibility to drug addiction still remain largely unknown. MiRNAs seem to play key roles in the drug-induced plasticity of the brain that likely drives the emergence of addiction. [...]
2017 - 10.1038/s41598-017-10207-2
Scientific reports, Vol. 7 (august 2017)
|
|
7.
|
8 p, 237.8 KB |
Anxiety and Depression in Drug-Dependent Patients with Cluster C Personality Disorders
/
Roncero, Carlos (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
de Miguel, Adelia (Universidad de La Laguna) ;
Fumero, Ascensión (Universidad de La Laguna) ;
Abad, Alfonso Carlos (Hospital Universitari Vall d'Hebron) ;
Martín, Rita (Universidad de La Laguna) ;
Bethencourt, Juan Manuel (Universidad de La Laguna) ;
Grau-López, Lara (Hospital Universitari Vall d'Hebron) ;
Rodríguez-Cintas, Laia (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Daigre, Constanza (Hospital Universitari Vall d'Hebron)
Comorbidity between personality disorders (PD) and substance-use disorders (SUD) is one of the most common findings in the psychiatric field. The patients with Cluster C disorders present maladjustment traits often characterized by high levels of anxiety. [...]
2018 - 10.3389/fpsyt.2018.00019
Frontiers in psychiatry, Vol. 9 (february 2018)
|
|
8.
|
8 p, 408.0 KB |
Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features
/
Grau-López, Lara (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Grau-López, Laia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Daigre, Constanza (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Palma-Álvarez, Raúl Felipe (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Martínez-Luna, Nieves (Hospital Universitari Vall d'Hebron) ;
Ros-Cucurull, Elena (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Ramos-Quiroga, Josep Antoni (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Roncero, Carlos (Universidad de Salamanca) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Background: Insomnia is highly prevalent in patients with substance use disorders (SUD), and it has been related to a worse course of addiction. Insomnia during detoxification in a hospital has not been adequately studied. [...]
2020 - 10.3389/fpsyt.2020.540022
Frontiers in psychiatry, Vol. 11 (november 2020)
|
|
9.
|
15 p, 2.4 MB |
ADGRL3 (LPHN3) variants predict substance use disorder
/
Arcos-Burgos, Mauricio (Universidad de Antioquia. Instituto de Investigaciones Médicas (IIM), Facultad de Medicina) ;
Vélez, Jorge I. (Universidad del Norte) ;
Martinez, Ariel F. (National Institutes of Health. Medical Genetics Branch, National Human Genome Research Institute) ;
Ribasés Haro, Marta (Hospital Universitari Vall d'Hebron) ;
Ramos-Quiroga, Josep Antoni (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Sánchez-Mora, Cristina (Hospital Universitari Vall d'Hebron) ;
Richarte, Vanesa (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Roncero, Carlos (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Cormand, Bru (Institut de Recerca Sant Joan de Déu) ;
Fernández-Castillo, Noelia (Institut de Recerca Sant Joan de Déu) ;
Casas Brugué, Miquel (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Lopera, Francisco (Universidad de Antioquia) ;
Pineda, David A. (Universidad de Antioquia) ;
Palacio, Juan D. (Universidad de Antioquia) ;
Acosta-López, Johan E. (Universidad Simón Bolívar. Grupo de Neurociencias del Caribe, Unidad de Neurociencias Cognitivas) ;
Cervantes-Henriquez, Martha L. (Universidad Simón Bolívar. Grupo de Neurociencias del Caribe, Unidad de Neurociencias Cognitivas) ;
Sánchez-Rojas, Manuel G. (Universidad Simón Bolívar. Grupo de Neurociencias del Caribe, Unidad de Neurociencias Cognitivas) ;
Puentes-Rozo, Pedro J. (Universidad del Atlántico. Grupo de Neurociencias del Caribe) ;
Molina, Brooke S. G. (University of Pittsburg. Departments of Psychiatry and Psychology) ;
Boden, Margaret T. (University of Kentucky Mental Health Research Center at Eastern State Hospital) ;
Wallis, Deeann (Texas A&M University. Department of Biochemistry and Biophysics) ;
Lidbury, Brett (The Australian National University. National Center for Indigenous Genomics, Genome Biology Department, John Curtin School of Medical Research, ANU College of Medicine, Biology and Environment) ;
Newman, Saul (The Australian National University. National Center for Indigenous Genomics, Genome Biology Department, John Curtin School of Medical Research, ANU College of Medicine, Biology and Environment) ;
Easteal, Simon (The Australian National University. National Center for Indigenous Genomics, Genome Biology Department, John Curtin School of Medical Research, ANU College of Medicine, Biology and Environment) ;
Swanson, James (University of California at Irvine. Child Development Center) ;
Patel, Hardip (The Australian National University. Genome Discovery Unit, Genome Biology Department, John Curtin School of Medical Research, ANU College of Medicine, Biology and Environment) ;
Volkow, Nora (National Institute on Drug Abuse (Rockville, Estats Units d'Amèrica)) ;
Acosta, Maria T. (National Institutes of Health. Medical Genetics Branch, National Human Genome Research Institute) ;
Castellanos, Francisco X. (Nathan Kline Institute for Psychiatric Research) ;
de Leon, Jose (University of Kentucky Mental Health Research Center at Eastern State Hospital) ;
Mastronardi, Claudio A. (Universidad del Rosario. Center for Research in Genetics and Genomics, Institute of Translational Medicine, School of Medicine and Health Sciences) ;
Muenke, Maximilian (National Institutes of Health. Medical Genetics Branch, National Human Genome Research Institute)
Genetic factors are strongly implicated in the susceptibility to develop externalizing syndromes such as attention-deficit/hyperactivity disorder (ADHD), oppositional defiant disorder, conduct disorder, and substance use disorder (SUD). [...]
2019 - 10.1038/s41398-019-0396-7
Translational psychiatry, Vol. 9 (january 2019)
|
|
10.
|
11 p, 319.6 KB |
Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder
/
Roncero, Carlos (Psychiatric Service, University of Salamanca Health Care Complex, Institute of Biomedicine of Salamanca, University of Salamanca) ;
Ryan, Pablo (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Littlewood, Richard (applied strategic) ;
Macías, Juan (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ;
Ruiz, Juan (Provincial Center of Drug Addiction) ;
Seijo, Pedro (Addiction Treatment Center of Villamartín) ;
Palma-Álvarez, Raúl Felipe (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Vega, Pablo (Institute of Addictions)
People with a history of injecting drugs have high prevalence of hepatitis C virus (HCV) infection, and many have opioid use disorder (OUD). Modern HCV therapies with improved efficacy and tolerability are available, but access is often limited for this group, who may be underserved for health care and face social inequity. [...]
2018 - 10.2147/HMER.S187133
Hepatic Medicine : Evidence and Research, Vol. 11 (december 2018) , p. 1-11
|
|